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Abstract
Background: Some of the biochemical events that lead to necrosis of the liver are well-known. However,
the pathogenesis of necrosis of the liver from exposure to hepatotoxicants is a complex biological
response to the injury. We hypothesize that gene expression profiles can serve as a signature to predict
the level of necrosis elicited by acute exposure of rats to a variety of hepatotoxicants and postulate that
the expression profiles of the predictor genes in the signature can provide insight to some of the biological
processes and molecular pathways that may be involved in the manifestation of necrosis of the rat liver.
Results: Rats were treated individually with one of seven known hepatotoxicants and were analyzed for
gene expression by microarray. Liver samples were grouped by the level of necrosis exhibited in the tissue.
Analysis of significantly differentially expressed genes between adjacent necrosis levels revealed that
inflammation follows programmed cell death in response to the agents. Using a Random Forest classifier
with feature selection, 21 informative genes were identified which achieved 90%, 80% and 60% prediction
accuracies of necrosis against independent test data derived from the livers of rats exposed to
acetaminophen, carbon tetrachloride, and allyl alcohol, respectively. Pathway and gene network analyses
of the genes in the signature revealed several gene interactions suggestive of apoptosis as a process
possibly involved in the manifestation of necrosis of the liver from exposure to the hepatotoxicants.
Cytotoxic effects of TNF-α, as well as transcriptional regulation by JUN and TP53, and apoptosis-related
genes possibly lead to necrosis.
Conclusion: The data analysis, gene selection and prediction approaches permitted grouping of the
classes of rat liver samples exhibiting necrosis to improve the accuracy of predicting the level of necrosis
as a phenotypic end-point observed from the exposure. The strategy, along with pathway analysis and gene
network reconstruction, led to the identification of 1) expression profiles of genes as a signature of
necrosis and 2) perturbed regulatory processes that exhibited biological relevance to the manifestation of
necrosis from exposure of rat livers to the compendium of hepatotoxicants.
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Background
Hepatotoxicity is one of the most commonly observed
adverse effects in response to many environmental and
toxic exposures and is of major concern in the drug devel-
opment industry [1]. The liver's response to insults
depends on the properties of the stressor, the dose
received and if the exposure is acute or chronic. Examples
of injury or damage are fatty liver, necrosis, cholestasis,
cirrhosis and cancer. Traditionally, the detection of a stres-
sor's toxicity relies on the evaluation of serum enzyme lev-
els that are indicators of tissue damage [2]. For instance,
elevations of ALT and AST are indicative of liver damage
[3]. They are associated with inflammation and\or injury
to hepatocytes. Necrosis of the liver usually results in
hepatocellular plasma membrane leakage of AST and ALT
into the bloodstream. However, although the elevated lev-
els of these serum enzymes are indicators of hepatocellu-
lar damage, they are poor prognosticators for the severity
of the liver injury or acute liver failure. The ability to pre-
dict necrosis at the molecular level, the extent (level) of
damage and the source of the insult is currently a chal-
lenge using classical toxicologic assays, parameters and
biomarkers.
Microarray analysis has evolved as a reliable technology to
survey the expression of genes across an entire genome
[4]. Several efforts have shown that gene expression signa-
tures can be "anchored" to the phenotype of biological
samples [5] and even characterize the genetic variability in
individuals [6,7]. The possibilities of phenotypic anchor-
ing are promising and just beginning to take form in
investigations from toxicogenomics and risk assessment
to pharmacogenomics and personalized medicine. Ulti-
mately, the success of these efforts relies on the identifica-
tion of genes and gene products that are considered
biomarkers of toxicity or candidates of susceptibility to
health conditions. Recently, Bushel et al. [8] have shown
that rat blood gene expression signatures are predictive of
the toxic exposure to acetaminophen and can be used to
monitor the exposure of the toxicant reflected in the
human blood and in the rat liver. The study was based on
a single hepatotoxicant which targeted a specific region of
the rat liver (centrilobular), addressed discrimination of
non\sub-toxic vs toxic (two class) and overdose exposure
levels and demonstrated the superiority of gene expres-
sion markers over traditional clinical parameters in pre-
dicting the exposure. A more comprehensive analysis of
compound-induced liver injury was performed ab initio
using samples exposed to hepatotoxicants or compounds
without known liver toxicity [9]. Expression profiles from
212 genes combined with a composite hepatotoxicity
score were highly predictive of compound-induced liver
injury. It would be useful to be able to identify gene
expression patterns as a diagnostic signature for predic-
tion of the (multiclass) level of necrosis as the general
phenotypic response that is commonly manifested from
toxic exposure to a compendium of stressors which targets
various regions of the liver.
In our study, gene expression data from rat livers exposed
to a compendium of hepatotoxicants (Lobenhofer et al.,
in press) was used to identify gene expression patterns as
a diagnostic signature which predicts the level of necrosis
of the liver with a high degree of accuracy. The eight chem-
ical compounds in the compendium (1,2-dichloroben-
zene, 1,4-dichlorobenzene, bromobenzene,
monocrotaline, N-nitrosomorpholine, thioacetamide,
galactosamine and diquat) elicit some or no hepatotoxic-
ity in male rat liver samples at one or more of the three
time points (with either a low, medium or high dose
exposure). A form of necrosis was the major lesion
observed in a region of the liver from the toxic doses of the
chemicals. Analysis of the liver and blood gene expression
data using SVM classifiers within each dose\time group
separately for each tissue type revealed compound-spe-
cific separation of the samples exposed to the hepatotoxi-
cant (Lobenhofer et al., in press). Interestingly, the blood
data consistently performed better than the liver data in
separating the samples into compound groups in the
majority of the dose\time point groups. To investigate the
ability of liver genomic markers to predict the level of
necrosis manifested in the livers of the animals exposed to
the hepatotoxicants, we utilized a Random Forest classi-
fier with an out-of-bag classification error and variable
importance estimation procedure to select gene predictors
of three classes of the level of necrosis that were derived
according to 1) the five severity scores of the injury 2) the
differentially expressed genes from an ANOVA model and
3) the Gene Ontology biological processes enrichment
shared by adjacent necrosis levels. From this strategy, gene
expression profiles from 21 informative genes were iden-
tified as a diagnostic signature which achieved 90%, 80%
and 60% prediction accuracies of the level of necrosis
against independent test data derived from rats exposed to
acetaminophen, carbon tetrachloride, and allyl alcohol,
respectively. In addition, it was determined that inflam-
mation follows programmed cell death in response to the
hepatotoxicants and the cytotoxic effects of TNF-α as well
as a transcriptional regulation by JUN and TP53, and
apoptosis-related genes possibly lead to necrosis.
Results
Manifestation of Necrosis
We used a data set containing 8 hepatotoxicants (see
Table 1) to identify genes related to necrosis level. Table 2
shows the distribution of the severity level of the animals
in each compound studied. The necrosis severity included
five levels: none, minimum, mild, moderate and marked.
None represents no sign of necrosis, minimal represents
less than 5% of hepatocytes show necrosis, mild repre-BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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sents 5%–25% of hepatocytes are necrotic, moderate
means 26%–50% of hepatocytes show necrosis and
marked means more than 50% of liver cells are necrotic.
Gene Expression Changes Transition with Severity of 
Necrosis
Given the groups of samples according to the manifesta-
tion of hepatocyte necrosis, we extracted genes from the
microarray data that have expression levels that are signif-
icantly different between severity levels. The severity levels
of necrosis were transformed to indicator variables 0, 1, 2,
3 and 4 denoting none, minimal, mild, moderate and
marked necrosis, respectively. An unbalanced one-way
ANOVA was constructed with the level of necrosis as the
only factor. To find significantly differentially expressed
genes between two adjacent necrosis levels, four estima-
tions of the comparison of necrosis score 0 vs. 1, 1 vs. 2, 2
vs. 3 and 3 vs. 4 were performed. Table 3 summarizes the
number of differentially expressed genes between two
adjacent necrosis scores under a series of Bonferroni
multi-test correction thresholds. The number of signifi-
cant differentially expressed genes for comparisons of
necrosis score 1 vs. 2 and score 3 vs. 4 are much fewer than
that for comparison of necrosis score 0 vs. 1 and score 2
vs. 3. This suggests that the expression of genes in the sam-
ples of the liver between minimal and mild necrosis and
between moderate and marked necrosis are not much dif-
ferent. The bulk of the difference is between liver samples
with no necrosis and those with minimal necrosis and
between those with mild necrosis and with moderate
necrosis.
Inflammation Follows Programmed Cell Death in 
Response to Hepatotoxicant Exposure
Gene Ontology analysis was performed on four lists of sig-
nificantly differentially expressed genes from the compar-
isons of two adjacent necrosis scores which met the
Bonferroni 0.05 threshold. Figure 1 shows GoMiner anal-
ysis of over-expressed genes from the four lists of gene.
The over-expressed genes in the comparison of necrosis
Table 1: Experimental design of the training and test samples
Compound Time (hr) Dose (mg/kg body weight) Observed Hepatotoxicity
Training Low Mid High
1,2-dichlorobenzene 6/24/48 15 150 1500 centrilobular necrosis
1,4-dichlorobenzene 6/24/48 15 150 1500 centrilobular necrosis
bromobenzene 6/24/48 25 75 250 centrilobular necrosis
diquat 6/24/48 5 10/20 25 centrilobular, midzonal, focal necrosis
galactosamine 6/24/48 25 100 400 multifocal necrosis
monocrotaline 6/24/48 10 50 300 centrilobular, midzonal necrosis
N-nitrosomorpholine 6/24/48 10 50 300 centrilobular necrosis
thioacetamide 6/24/48 15 50 150 centrilobular necrosis
Test
acetaminophen (NCT 008) 6/24/48 50 150 1500/2000
acetaminophen (NTP) 6/18/24/48 50 150 1500/2000 centrilobular necrosis
acetaminophen (informatics challenge) 3/6/12/24 150 1500/2500
carbon tetrachloride 3/6/24/72 15 750 2000 centrilobular necrosis
Ally Alcohol 6/24/48/72 10 20 40/50 periportal necrosis
Table 2: Necrosis severity and distribution in each compound study of the training data
Necrosis Observation (% of hepatocytes showing necrosis) No Sign <5% 5%–25% 26%–50% >50% Sample size
Necrosis Level 0 1 2 3 4
1,2-dichlorobenzene 17 8 5 2 2 34
1,4-dichlorobenzene 31 4 1 0 0 36
bromobenzene 16 7 5 0 8 36
diquat 50 10 6 4 2 72
galactosamine 18 7 8 2 1 36
monocrotaline 16 11 1 0 4 32
N-nitrosomorpholine 12 17 2 1 4 36
thioacetamide 4 18 1 6 7 36
Total sample size 164 82 29 15 28 318BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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score 1 vs. 2 and score 3 vs. 4 do not show any significant
biological processes, while the over-expressed genes in the
comparison of necrosis score 0 vs. 1 and 2 vs. 3 yielded
several significant biological processes. One example is
the biological process for inflammatory response. It is
over-represented in the gene set discriminating necrosis
level 2 and 3 but not when comparing level 0 and 1. The
programmed cell death pathway is over-represented in
this latter comparison. Therefore, it appears that after
exposure of the liver to these hepatotoxicants in rats, pro-
grammed cell death is activated in the samples that exhib-
ited mild or minimal necrosis while the inflammatory
response is activated in the liver samples showing moder-
ate or marked necrosis. These results, suggesting that
inflammation follows programmed cell death, are in-line
with recent finding that the mechanisms by which apop-
tosis promotes an inflammatory response may be related
to death receptor-initiated signaling cascades [10,11].
Both the ANOVA statistical analysis and GoMiner biolog-
ical processes analysis resulted in the conclusion that the
gene expression, biological pathways and processes in the
liver samples that manifest minimal or mild necrosis are
very similar and difficult to differentiate from one
another. The same is the case for liver samples revealing
moderate or marked necrosis. However, the biological
response in the liver of the samples with necrosis level
comparisons of none vs. minimum and mild vs. moderate
resulted in significant biological differences. Thus, for the
purpose of this study, we combined the five necrosis
severity scores into three necrosis levels, (no necrosis as
level 0, minimal and mild necrosis as level 1, and moder-
ate and marked necrosis as level 2) in order to identify
genes that can predict the level of necrosis with a high
degree of certainty from samples that share a common
biological response. In the end, the sample size in each
level increases and the statistical power to differentiate the
newly defined levels of necrosis improves.
Gene Classifiers that Predict Necrosis
Selection of Predictor Genes
First, a one-way ANOVA was fitted to extract the signifi-
cant differentially expressed genes among the three newly
defined necrosis levels. The same one-way ANOVA model
as described above was applied with the modification that
the necrosis level now was from 0 to 2 instead of from
severity score 0 to 4. Three contrasts were performed to
identify differentially expressed genes between level 0 vs.
1, 1 vs. 2 and 0 vs. 2. From this analysis, 8561 genes were
significantly differentially expressed either in the contrast
of level 0 vs. 1 or in the contrast of level 1 vs. 2 using Bon-
ferroni multi-test correction at p-value threshold of 0.05
(See Additional file 1). Gene Ontology analysis per-
formed on the two gene lists generated from the 0 vs. 1
and 1 vs. 2 level comparisons from the redefined groups
reconfirms that inflammation follows programmed cell
death when the samples are exposed to the hepatotoxi-
cants (See Additional file 2 and See Additional file 3).
Inflammation is significant only in the 1 vs. 2 comparison
while program cell death is more significant in 0 vs. 1
comparison.
For building a model for prediction, all the normalized
data from the 318 arrays (treated animals) were used as a
training set. The three necrosis levels were used as the class
labels and the 8561 genes as the predictors. Random For-
est and GEMS-SVM were two classification approaches
used for prediction.
Prediction with Random Forest
The Random Forest classification method selected 21
genes which have an out-of-bag (OOB) data error rate of
0.104 and standard deviation of 0.017. The names and
annotation of the 21 selected genes are listed in Table 4.
The list contains several genes related to inflammatory
disease, cell-to-cell signaling and interaction, cell death,
cellular movement, immune response, and cell organiza-
tion.
Prediction with GEMS
Classifiers used for prediction can be data dependent.
Therefore, we also used the Gene Expression Model Selec-
tor (GEMS) approach for prediction. The best performing
model selected by GEMS used a gene selection method
consisting of a signal-to-noise ratio in a one-versus-rest
fashion followed by a multicategory support vector
machines method by Weston and Watkins [12]. Six genes
were selected from the prediction model achieving a min-
imum cross validation error with prediction accuracy of
89.6% on the training data (Tables 5 and 6). Five of the six
Table 3: Number of DEGs between two adjacent necrosis levels after Bonferroni multi-test correction
Bonferroni p-value threshold level 1 vs. 0 level 2 vs. 1 level 3 vs. 2 level 4 vs.3
0.0001 1592 14 336 31
0.001 1960 33 490 50
0.01 2404 90 695 91
0.05 2683 171 910 131
* A total of 20,500 genes from the Agilent platform were tested.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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High-Throughput GoMiner analysis of 4 groups of over-expressed genes Figure 1
High-Throughput GoMiner analysis of 4 groups of over-expressed genes. There are 4 groups of significantly differen-
tially expressed gene lists, one for comparison of necrosis level 0 vs. 1 with 2683 significant genes, one for comparison of 
necrosis level 1 vs. 2 with 171 significant genes, one for comparison of necrosis level 2 vs. 3 with 910 significant genes, and one 
for comparison of necrosis level 3 vs. 4 with 131 significant genes. The four gene lists are labeled on the bottom of the figure 
and over-represented biological processes are labeled at the left of the figure. The red color indicates that the p-value is 
smaller than the FDR rate of 0.05 whereas blue represents p-values larger than an FDR rate of 0.05. The smaller the p-value, 
the more intense the color.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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genes were also selected as predictors using the Random
Forest approach except for inosine monophosphate
(IMP) dehydrogenase 1. This gene catalyzes the rate-limit-
ing reaction of de novo GTP biosynthesis at the inosine
monophosphate metabolic branch point and therefore is
involved in the regulation of cell proliferation. The predic-
tion results on the training and test data from both classi-
fiers are showed (See Additional file 4).
Comparison of Results Between Random Forest and GEMS
The same average prediction accuracy of 89.6% on the
training data was achieved using the 21 genes selected by
Random Forest and the 6 genes selected by the GEMS-
SVM classifier (Table 6). Comparison of the prediction
calls for the training data set from the two approaches
indicates that the GEMS-SVM approach tends to misclas-
sify samples towards the lower end of the necrosis level
than the Random Forest approach (Table 7). Assessing the
prediction accuracy for each compound in the training
data set revealed that different compounds show different
prediction accuracies, ranging from 83.3% to 100%
(Table 6). The thioacetamide, monocrotaline, galactos-
amine, and diquat exposed samples always showed lower
prediction accuracies (between 83%–89%) using both the
Random Forest and GEMS-SVM approaches. The bro-
mobenzene, 1,4-dichlorobenzene and N-nitrosomorpho-
line exposed samples were typically predicted with
accuracies greater than 94% using either the Random For-
est or GEMS-SVM approaches. The samples exposed
to1,2-dichlorobenzene show better prediction accuracy
using the Random Forest approach than the GEMS-SVM
approach.
Table 4: Annotation of the 21 selected Agilent probes using the Random Forest classification approach
Agilent Probe Gene Acc. # Gene Name Description
A_42_P458530 NM_139342 Ripk3 Rattus norvegicus receptor-interacting serine-threonine kinase 3 (Ripk3)
A_42_P487811 AW914054 Sema4g_predicted Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4G (predicted)
A_42_P507284 NM_013111 Slc7a1 Rattus norvegicus solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 1 (Slc7a1)
A_42_P517381 NM_133298 Gpnmb Rattus norvegicus glycoprotein (transmembrane) nmb (Gpnmb)
A_42_P532103 NM_019905 Anxa2 Rattus norvegicus annexin A2 (Anxa2)
A_42_P594863 AI144754 Rnd1 Rho family GTPase 1 (predicted)
A_42_P621642 XM_341964 Lsp1 Rattus norvegicus similar to Lsp1 protein (LOC361680)
A_42_P695401 NM_031530 Ccl2, MCP-1 Rattus norvegicus chemokine (C-C motif) ligand 2 (Ccl2)
A_42_P710382 BF412297 TC466815 Transcribed locus
A_42_P730684 XM_214096 LOC289801 Rattus norvegicus similar to uridine phosphorylase (LOC289801)
A_42_P768467 BQ207775 RGD1305887 Similar to RIKEN cDNA 2310057H16 (predicted)
A_42_P809565 NM_139324 Ehd4 Rattus norvegicus EH-domain containing 4 (Ehd4)
A_43_P10621 AI177116 Vasp_predicted Vasodilator-stimulated phosphoprotein (predicted)
A_43_P11353 BC083855 Lcp1 Lymphocyte cytosolic protein 1 (predicted)
A_43_P11621 NM_012924 Cd44 Rattus norvegicus CD44 antigen (Cd44)
A_43_P12519 NM_031114 S100a10 Rattus norvegicus S100 calcium binding protein A10 (calpactin) (S100a10), mRNA 
[NM_031114]
A_43_P12698 NM_031832 Lgals3 Rattus norvegicus lectin, galactose binding, soluble 3 (Lgals3)
A_43_P12940 NM_053812 Bak1 BCL2-antagonist/killer 1
A_43_P13182 NM_133416 Bcl2a1 B-cell leukemia/lymphoma 2 related protein A1
A_43_P14045 AW914054 Sema4g_predicted Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4G (predicted)
A_43_P15660 BC079312 Cxcl16 similar to chemokine (C-X-C motif) ligand 16
Table 5: Annotation of the 6 selected Agilent probes using GEMS-SVM
Agilent Probe Gene Acc. # Gene Name Description
A_42_P458530 * NM_139342 Ripk3 Rattus norvegicus receptor-interacting serine-threonine kinase 3 (Ripk3)
A_42_P507284 * NM_013111 Slc7a1 Rattus norvegicus solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 1 (Slc7a1)
A_42_P695401 * NM_031530 Ccl2, MCP-1 Rattus norvegicus chemokine (C-C motif) ligand 2 (Ccl2)
A_42_P768467 * BQ207775 RGD1305887 Similar to RIKEN cDNA 2310057H16 (predicted)
A_43_P11307 XM_342650 Impdh1_predicted Rattus norvegicus similar to Impdh1 protein (LOC362329)
A_43_P11621 * NM_012924 Cd44 Rattus norvegicus CD44 antigen (Cd44)
* Overlap with the 21 selected Agilent probes using Random ForestBMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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Both the Random Forest classifier and GEMS-SVM classi-
fier misclassified 33 animals from the training set. There
are 24 animals in the overlap; thus, a total of 42 animals
were misclassified either from the Random Forest
approach or from the GEMS-SVM approach. Further veri-
fication using clinical chemistry data was performed for
animals where there was disagreement between the pre-
dicted necrosis level and the necrosis class label according
to the redefined groups (See Additional file 5). The corre-
lation analysis (Table 8) and scatter plot (Figure 2) were
performed on the data to identify the concordance of
log2ALT/log2AST level, the predicted class label, and the
necrosis class label based on the redefined groups. The
Random Forest and GEMS-SVM predicted labels for the
misclassified samples were more consistent with ALT and
AST levels than the necrosis class label (Figure 2, Table 8).
The Random Forest and GEMS-SVM predicted labels for
the correctly classified samples were just as consistent
(correlations > +0.83) with log2ALT and log2AST levels as
the necrosis class label (Data not shown). This result cor-
roborates our prediction call. Comparing the scatter plot
colored by the Random Forest predicted label (Figure 2b)
vs. colored by the GEMS-SVM predicted label (Figure 2c)
on those misclassified samples revealed that the Random
Forest method tends to predict the samples more towards
a severe necrosis level while the GEMS-SVM approach
tends to predict them towards a less severe necrosis level
(see Table 7 as well). Figure 3 is a principal component
analysis (PCA) on all 318 training animals using the 21
selected genes illustrating the level of necrosis separated
along the PC1. Figure 3a is colored by the necrosis class
label and Figure 3b is colored by the predicted label. Both
figures show that the level of necrosis increases from left
to right along the PC1.
To validate the prediction using the selected genes, the
classifier was applied to the test data. The chemical com-
pounds in the testing data sets (see Table 1) include three
different studies of rat livers exposed to acetaminophen,
one to carbon tetrachloride and one to allyl alcohol.
When the Random Forest classifier was applied to the
acetaminophen-treated sample data, the prediction accu-
racies were 88.9%, 87.5% and 90.7% respectively for the
data sets from the National Center for Toxicogenomics
study #8 (NCT008), National Toxicology Program (NTP)
and National Center for Toxicogenomics informatics
challenge study (NCT informatics challenge). The Ran-
dom Forest classifier produced 77.8% prediction accuracy
for the carbon tetrachloride-treated test samples. Surpris-
ingly, only 64.2% prediction accuracy was achieved with
the classifier applied to the allyl alcohol-treated test sam-
ples (Table 6). Similarly, the GEMS-SVM classifier with
the 6 predictive genes achieved prediction accuracies of
88.9%, 87.5% and 89.8% respectively for three acetami-
nophen data sets from NCT008, NTP and NCT informat-
ics challenge. In the case of the carbon tetrachloride test
samples, the GEMS-SVM classifier achieved the same pre-
diction accuracy (77.8%) as the Random Forest classifier.
Not surprisingly, similar to the Random Forest prediction
of the test data, the GEMS-SVM classifier model per-
formed poorly on the allyl alcohol sample set achieving
Table 6: Prediction accuracy of the training and test data sets using Random Forest and GEMS-SVM
Compounds Sample size Prediction Accuracy
Random Forest GEMS
Training 1,2-dichlorobenzene 34 91.20% 85.30%
1,4-dichlorobenzene 36 94.40% 94.40%
bromobenzene 36 100% 94.40%
diquat 72 86.10% 88.90%
galactosamine 36 83.30% 86.10%
monocrotaline 32 84.40% 84.40%
N-nitrosomorpholine 36 94.40% 100%
thioacetamide 36 86.10% 83.30%
All training 318 89.60% 89.60%
Test acetaminophen (NCT) 36 88.90% 88.90%
acetaminophen (NTP) 64 87.50% 87.50%
acetaminophen (Informatics Challenge) 108 90.70% 89.80%
carbon tetrachloride 72 77.80% 77.80%
Ally Alcohol 95 64.20% 59%
Table 7: Prediction accuracy for all the training data samples 
using Random Forest and GEMS-SVM
Random Forest GEMS
Predict Predict
01 2 0 1 2
TRUE 0 151 12 1 155 9 0
11 19 461 5 9 4 2
20 3 4 0 0 7 3 6BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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only 59% prediction accuracy. Generally speaking, the
GEMS-SVM classifier model performed slightly worse
than the Random Forest model on the test data, probably
due to the smaller number of genes in the former model.
To test the significance of the 21 genes in the classifier
10,000 samples were generated by randomly selecting 21
genes from the array to use for training of the Random
Forest classifier and testing on the test data. The median
prediction accuracy for the 10,000 randomly generated
samples is 70%. About 4.7% of the random samples
achieved a prediction accuracy greater than 76%. Only 4
out of the 10,000 samples achieved prediction accuracy
greater than or equal to 0.81 (accuracy for the 21 genes
using the Random Forest classifier). Therefore, the signif-
icance of the prediction accuracy of the selected 21 genes
in the Random Forest classifier has a p-value < 0.0005.
The scatter plot of log2 (ALT) and log2 (AST) levels of all 42 disagreement animals from Random Forest and GEMS-SVM clas- sifier colored by the class label Figure 2
The scatter plot of log2 (ALT) and log2 (AST) levels of all 42 disagreement animals from Random Forest and 
GEMS-SVM classifier colored by the class label. (a) The scatter plot is colored by the necrosis class label according to 
the redefined groups; (b) The scatter plot is colored by the Random Forest predicted label; (c) The scatter plot is colored by 
the GEMS-SVM predicted label.
Table 8: Correlation analysis of ALT and AST with the necrosis class, Random Forest predicted or GEMS-SVM predicted label
Necrosis class label GEMS_pred RF_pred Log2ALT Log2AST
Necrosis class label 1
GEMS_pred 0.095585 1
RF_pred 0.146186 0.680875 1
Log2ALT 0.448879 0.749506 0.758779 1
Log2AST 0.417822 0.778307 0.743858 0.990228 1BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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PCA using the 21 selected genes Figure 3
PCA using the 21 selected genes. The necrosis levels increase from left to right. The red color represents animals with 
necrosis label 0, blue represents animals with necrosis label 1 and green represents necrosis level 2. The color in (a) represents 
the original class label, while in (b) the color represents the Random Forest predicted class label.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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Biological Pathway and Gene Network Analyses
Pathway analysis of the 21 predictor genes revealed a cen-
tral regulating role of tumor necrosis factor (TNF), Jun
and TP53 (Figure 4). The majority of the predictor genes
(17 out of 21) are regulated in their expression by those
transcription factors. Bayesian gene networks were recon-
structed using the discretized expression profile of all
mapped genes from the training samples. The edges
between the genes denote inferred interactions. Animals
treated with a low dose (i.e. non-toxic dose) of the agents
don't usually manifest necrosis. Only samples treated
with a high dose (i.e. the more toxic dose) of the agents
were selected (including the samples from the training
data set excluding 1,4-dichlorobenzene) for reconstruc-
tion of the Bayesian networks. The networks with the
highest posterior probability of the model given the data
Pathway analysis Figure 4
Pathway analysis. The 21 gene probes corresponding to 20 genes, were analyzed by Ingenuity Pathway Analysis software 
version 5.1. Eighteen out of 20 genes were annotated for gene network construction. Seventeen out of 20 over-expressed 
genes were mapped to the same network space. The red nodes represent the 17 selected genes. The pathway analysis 
revealed a central regulating role of tumor necrosis factor (TNF), Jun and TP53.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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were collected from a large number of heuristic searches.
The frequency distribution histogram (Figure 5) details
the number of edges that reoccur in the 500 networks that
were reconstructed. There are potentially 1024 edges for
the 32 genes used to generate the networks (including the
self-directed edge), 837 edges not presented (found zero
times), 17 edges presented over 400 times, and 10 edges
presented between 300 and 400 times. The probability of
each edge being presented was calculated using weighted
average scoring. Figure 6 shows the consensus network
recreated using the highest scoring network from each of
the 500 runs of the algorithm, including all edges with a
probability of being presented greater than 0.6. Four gene-
to-gene interactions (S100 Calpactin [S100a10] with
annexin A2 [Anxa2], Lectin, galactose binding, soluble 3
[Lgals3] with Epidermal Langerhans cell protein [Lcp1],
Tumor protein p53 [TP53] with Cathepsin H [Ctsh] and
Mitogen activated protein kinase 1 [Mapk1] with Caspase
8 [Casp8]) with probabilities greater than 0.8 are consist-
ent with the interactions in the biological pathway gener-
ated from curation of scientific literature (Figure 4).
Discussion
Hepatotoxicants particularly target the liver and cause a
variety of liver injuries. One type of damage is necrosis, a
degenerative process leading to cell death. We analyzed a
compendium of gene expression data (see Lobenhofer et
al., in press) acquired from rat livers exposed to hepato-
toxicants in an attempt to define gene expression patterns
as a signatures that are highly predictive of the level of
necrosis. We used necrosis as a phenotypic anchor to iden-
tify genes which predict the level of necrosis of the rat liver
with a high degree of accuracy.
A prevailing advantage of our study was identifying genes
related to necrosis which may be directly related to cell
death caused by exposure to the compounds while filter-
ing out genes related to other mechanisms related to a sin-
gle compound. This was accomplished by using the
histopathologic class label of the biological samples for
necrosis as defined by board certified pathologists. We
then leveraged ANOVA pairwise contrasts of the severity
groups and GoMiner analysis of the gene expression data
to subset the samples into groups with similar phenotypic
changes exhibited by necrosis of the liver and comparable
overrepresentation of biological processes (Figure 1).
Using these groups as class labels for the level of necrosis
in the training set and two gene selectionification
approaches (Random Forest and GEMS-SVM), we were
able to identify subsets of genes which yielded a low pre-
diction error rate during cross validation of the classifiers.
Preliminary analysis of the liver gene expression data
within each dose\time group by Lobenhofer et al. (in
press) revealed compound-specific separation of the sam-
ples. Although classification of the blood data was better
in higher dose groups at the later time points as compared
to the liver data, classifiers derived from it was not able to
predict animals in some cases where the hepatotoxicant
elicited a different phenotypic response with the animals
of a particular dose\time group. Interestingly, concord-
ance analysis of ALT and AST enzyme levels with the class
label of the level of necrosis and our predicted class labels
revealed that the latter is more consistent with the enzyme
levels. One potential reason for this could be that the
microarray samples are from the whole liver whereas the
histopathology samples used for scoring the extent of
necrosis are only from two independent slices of the liver
specimen. In a limited study, Heinloth et al. [13] also
showed that gene expression analysis is more informative
than histopathologic evaluations and offers unique
advantages to liver biopsy evaluations. Another explana-
tion could be that certain animals may develop the phe-
notype at a later time point after treatment than the time
point when the samples were taken for analysis. There-
fore, the histopathology samples may not completely rep-
resent the liver toxicity. However, our gene expression
analysis, redefining of the class labels for the level of
necrosis exhibited in the samples and selection of predic-
tor genes for necrosis are geared towards capturing the
biological processes and mechanistic pathways that may
govern the manifestation of the phenotype from a low
level of necrosis to its highest level.
Using independent gene expression data sets acquired
from the exposure of rat liver samples to a different set of
hepatotoxicants, we show that the prediction accuracies of
Histogram of the number of edges reoccurring in 500 net- works Figure 5
Histogram of the number of edges reoccurring in 500 
networks. The 187 possible edges present in at least one of 
500 networks are plotted. The 107 out of 187 edges are pre-
sented less than 25 times in 500 networks. The x-axis is the 
number of occurrences of the edges and the y-axis is the fre-
quency.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
Page 12 of 16
(page number not for citation purposes)
either of the two classifiers were roughly 80% overall but
approximately 90%, about 80% and around 60% for
acetaminophen-, carbon tetrachloride- and allyl alcohol-
exposed samples, respectively with a p-value < 0.0005 for
the significance of the prediction using the Random Forest
classifier (Table 6). The dramatic difference in prediction
accuracy could be related to bioactivation mechanisms
involved in the manifestation of centrilobular necrosis in
the case of acetaminophen- and carbon tetrachloride-tox-
icity as opposed to periportal necrosis in the case of allyl
alcohol-toxicity. In the former, the abundance of cyto-
chrome P450 plays a critical role whereas in the latter,
higher oxygen levels are responsible [2]. Another reason
may be a site-specific batch effect since the allyl alcohol
microarray data was generated at a different location than
the acetaminophen and carbon tetrachloride microarray
data. The training and testing samples are plotted together
using PCA of the expression data from the signature of the
21 selected genes (See Additional file 6). The testing sam-
ples show similar distributions as the training samples
and also indicate that the necrosis level increases from
right to left along PC1. The acetaminophen- and carbon
tetrachloride – exposed samples show a similar data dis-
persion range as the training samples while the ally alco-
hol – exposed samples are more compressed along the
first PC.
Genes from our predictive models (See Tables 4 and 5)
have biological functions related to the regulation of
apoptosis (Ripk3 and Bcl2a1) or are involved in a chem-
okine\inflammatory response (Ccl13 also known as
CCL2/MCP-1), Cxcl16 and Lgals3. Pathway analysis of
the predictor genes revealed a central regulating role of
tumor necrosis factor (TNF), Jun and TP53 (Figure 4). The
majority of the predictor genes in the signature (17 out of
21) are regulated in their expression by these transcription
factors. Therefore, our results are generally in agreement
with the current hypothesis that TNF mediates liver injury
and genes such as Jun and TP53 are closely involved in
necrotic changes in response to exposure to some hepato-
toxicants [14-21]. Surprisingly, monocyte chemoattract-
ant protein-1 (MCP-1), a serum factor gene and
chemokine that is in our predictor gene list, was shown to
have its protein product differentially expressed in aceta-
minophen-treated rats [22] and is induced by TNF-α [23].
This regulation might be a reflection of a repair process
following liver injury by acetaminophen-toxic exposure
or could be a contributor to the insult. Although the role
of MCP-1 in liver injury is controversial [22], new evi-
dence using MCP-1 deficient mice suggests that interfer-
ence of the gene's expression is sufficient for altering the
processes that lead to severe carbon tetrachloride-induced
liver injury [24]. However, caution must be taken as a
more complicated biological response to liver injury is
likely since there are hepatotoxicants, such as monocrota-
line – (MCT, a pyrrolizidine alkaloid plant toxin), where
an inflammatory response ensues secondarily to injury of
the liver and TNF-α appears to not be primarily responsi-
Reconstructed (consensus) gene network Figure 6
Reconstructed (consensus) gene network. The reconstructed Bayesian network was generated from the gene expres-
sion data from a total of 32 gene profiles. It depicts the statistical dependence between the transcript levels of the genes. The 
red nodes represent the up-regulated genes and green nodes represent the down-regulated genes both when the necrosis 
severity increases. Blue edges have a probability greater than 0.9, brown edges between 0.8 to 0.9, and black edges between 
0.6 to 0.8. The dashed lines represent the edges consistent with the Ingenuity Pathway Analysis in Figure 4.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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ble for the hepatotoxicity [25]. In addition, transcription
factors such as TNF-α and TP53 have both pro- and anti-
apoptotic effects. TP53 keeps the cell from progressing
through the cell cycle if there is damage to DNA but can
also cause the cell to enter apoptosis if the damage cannot
be repaired. Similarly, TNF-α can induce pro-apoptotic
signaling mechanisms [26] or induce resistance against
apoptosis [27] depending on the overall condition of the
cell and its microenvironment.
The reconstructed Bayesian network from the toxic expo-
sures of the hepatotoxicants (Figure 6) revealed several
gene interactions that are consistent with interactions in
the pathway that was generated from curated scientific lit-
erature (Figure 4) and points to apoptosis-related genes in
necrosis-mediated toxicity. Bear in mind that the network
is a consensus one, has only positive, one-way, acyclic
interactions and was generated from microarray data
alone using a limited number of genes. However, the con-
fidence of each gene-to-gene edge (interaction) was calcu-
lated by performing 500 simulated annealing searches.
Conclusion
We have demonstrated that gene expression signatures
can predict, with a high degree of accuracy, the severity of
necrosis of the liver elicited by acute exposure of rats to a
variety of hepatotoxicants. First, the class discovery
approach using ANOVA and GoMiner pathway analysis
provided well-defined groups. This step is important since
the redefined groups are more correlated with the liver
injury as measured by ALT and AST enzyme levels. In
addition, the gene selection strategy using Random Forest
and GEMS-SVM improved the accuracy of predicting the
severity of necrosis. Furthermore, the gene expression sig-
nature led to the identification of the molecular pathways
that exhibited biological relevance to the manifestation of
necrosis. Finally, pathway and gene network analyses
revealed several gene interactions suggesting that apopto-
sis may be a consequence of the chain of events stemming
from drug-induced liver injury and it leads to, or is con-
comitant with, the manifestation of necrosis of the liver
from exposure of the hepatotoxicants in rats.
Methods
Experimental Design
The training data set is comprised of studies from the
exposure of rats to one of eight compounds (1,2-dichlo-
robenzene, 1,4-dichlorobenzene, bromobenzene,
monocrotaline, N-nitrosomorpholine, thioacetamide,
galactosamine and diquat). All eight compounds were
studied using standardized procedures, i.e. a common
array platform, experimental procedures and data retriev-
ing and analysis processes [28] (Lobenhofer et al., in
press). For each compound, four to six male, 12 week old
F344 rats were exposed to a low dose, mid dose(s) and a
high dose of the toxicant and sacrificed at 6, 24 and 48 hr
later (Table 1). At necropsy, liver and blood were har-
vested for RNA extraction, histopathology, clinical chem-
istry and hematology assessments. For liver RNA, left liver
lobes were flash frozen, pulverized, and RNA was
extracted from a portion of the powder with the QIAGEN
RNeasy Maxi Kits (QIAGEN, Valencia, CA). The test data
is comprised of three compound data sets (acetami-
nophen, carbon tetrachloride, and ally alcohol). Acetami-
nophen data sets were collected from three different
independent studies (NCT008, NTP and NCT informatics
challenges). Studies used in the test data are not from the
standardized procedures. For both the training and test
samples, a time-matched vehicle control pool was made
for each compound and each tissue by pooling equal
amounts of RNA from each of the four control animals.
Each treated animal was hybridized against a time
matched control pool to the Agilent Rat Oligonucleotide
Microarray (Agilent #G4130A) with a dye-swap technical
replicate. Fluorescence intensities were measured with an
Agilent DNA Microarray Scanner (Agilent G2565AA) and
processed with the Agilent G2565AA Feature Extraction
software.
Normalization of the Microarray Data
The log10-ratio intensity value for each gene feature on the
array was retrieved from the raw file of each array. Each
array was normalized by subtracting the sample-median
value. Then the dye-swap arrays from the same biological
replicate were merged by averaging. After dye-swap merg-
ing, there were a total of 318 arrays, one for each treated
animal.
Histopathology
From the left liver lobes, two sections were taken and fixed
in 10% formalin. After dehydration with ethanol, the liver
sections were embedded in paraffin and H&E stained
slides were made. These slides were evaluated by two
independent pathologists and disagreements were
resolved by a pathology working group review [29]. Hepa-
tocyte necrosis was one of the observed lesions. The sever-
ity of necrosis was graded into 5 levels (none, minimal,
mild, moderate and marked) by pathologists according to
the percentage of hepatocytes that show necrosis (Table
2). The necrosis observation severity levels were then used
as a class label for the samples in the training and test data
sets.
Clinical Chemistry
At sacrifice, blood was collected into serum separation
tubes (BD Microtainer® Tubes, BD, Franklin Lakes, NJ)
and serum was separated. Clinical chemistry analyses
(albumin, cholesterol, creatinine, direct bilirubin, total
bilirubin, total bile acid concentrations, triglycerides, and
activities of alanine aminotransferase [ALT], alkalineBMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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phosphatase, aspartate aminotransferase [AST], lactate
dehydrogenase [LDH] and sorbitol dehydrogenase
[SDH]) were performed on all rats at study termination.
Serum levels of the established liver injury markers ALT
and AST increase when the liver shows inflammation or
hepatotoxicity.
One-way ANOVA
To identify the genes that are significantly differentially
expressed among the different levels of necrosis, an unbal-
anced one-way ANOVA was fitted for each gene,
Yij = μ + Ni + εij, where
i = 0...m (level of necrosis)
j = 1...ni, ni is the number of rats in necrosis level i.
Yij, the gene expression value at the jth rat of ith necrosis
level
μ, the mean of the expression of the gene for all rats from
all necrosis levels
Ni, the necrosis effect of the gene at level i
εij, the expression deviation of the gene at jth rat from the
necrosis effect of level i
The number of rats in the different necrosis levels is differ-
ent, leading to an unbalanced design with different num-
bers of replicates in each level of the necrosis factor. The
significantly differentially expressed genes between two
adjacent necrosis levels were identified by estimation
statements. Bonferroni multi-test corrections are applied.
Biological Processes Analyses
The gene symbols for all genes features on the Agilent chip
were retrieved from the Stanford Genomics Resources
S.O.U.R.C.E. database and used as the input of High-
Throughput GoMiner [30]. GoMiner is used to test if
selected genes in a gene list are over-represented for a par-
ticular biological process. Here, the total genes are all
genes from the chip and the selected genes are the ones
identified as significantly differentially expressed. The
over-expressed genes and under-expressed genes of the
selected differentially expressed genes were tested sepa-
rately. For each gene list, every biological process was
assessed for significance based on the Fisher's exact test
and a p-value assigned based on the hypergeometric prob-
ability distribution. All p-values from each combination
of a biological process and gene list were filtered using a
false discovery rate (FDR) at 0.05, clustered and visualized
using JAVA Treeview [31].
Gene Selection and Classification Methods
Random Forest
The Random Forest classification approach grows many
single classification trees and chooses the most popular
vote over all trees in the forest [32]. Each tree uses the ran-
domly selected samples (with replacement) as the train-
ing set. About one-third of the cases are left out of the
selected samples, which is called the out-of-bag (OOB)
data. The OOB data is used as the testing data to get an
unbiased estimate of the classification error and to esti-
mate variable importance. Two R packages, randomForest
and varSelRf were used in the Random Forest classifica-
tion.
GEMS
Gene Expression Model Selector provides several SVM-
based binary or multi-category classification methods and
several gene selection methods [33]. The software con-
structs and estimates models from all combinations of
gene selection methods and classification methods, then
reports the models with the minimum cross-validation
error. This is a filtering approach to rank genes by the
selection method and then include them (step by step
from the top ranked one to the bottom ranked one) into
the model. Ten-fold nested cross-validation was used to
provide an unbiased estimation of the model perform-
ance. A linear polynomial kernel was selected for the SVM.
Gene Network Reconstruction
Genes identified as significantly differentially expressed
and then selected as a predictor from the Random Forest
classifier were used in the Ingenuity Pathway Analysis
(IPA) software (Ingenuity Systems, Redwood City, CA) to
identify biological pathways that the genes are a compo-
nent of. All genes within the network space from the path-
way analysis were collected, their Agilent probes mapped
and expression profiles retrieved. Thus, a total of 32 gene
profiles were used for gene network reconstruction. Baye-
sian Network Inference with Java Objects (BANJO) devel-
oped by Dr. Alexander Hartemink was used to build
Bayesian networks from the data [34]. The 32 gene pro-
files across 318 arrays were discretized into three levels
using the prior frequencies of each class. Only 84 samples
from the high dose treatments of the hepatotoxicants
(except for 1,4-dichlorobenzene) were used for the net-
work reconstruction. In each run, a heuristic algorithm
based on simulated annealing searches for the net-
work\model with the highest posterior probability of
being generated from the data. We ran the algorithm 500
times and gathered the highest scoring network from
each. The probability of the edges being presented was
computed using weighted average scoring from all the
models [35]. If an edge is presented in all 500 runs, the
probability of it is exactly 1.BMC Genomics 2008, 9:288 http://www.biomedcentral.com/1471-2164/9/288
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